JP2021504421A5 - - Google Patents

Download PDF

Info

Publication number
JP2021504421A5
JP2021504421A5 JP2020529538A JP2020529538A JP2021504421A5 JP 2021504421 A5 JP2021504421 A5 JP 2021504421A5 JP 2020529538 A JP2020529538 A JP 2020529538A JP 2020529538 A JP2020529538 A JP 2020529538A JP 2021504421 A5 JP2021504421 A5 JP 2021504421A5
Authority
JP
Japan
Prior art keywords
synthetic composition
hmo
gluten
wheat
humans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020529538A
Other languages
English (en)
Japanese (ja)
Other versions
JP7327724B2 (ja
JP2021504421A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/059497 external-priority patent/WO2019106618A1/en
Publication of JP2021504421A publication Critical patent/JP2021504421A/ja
Publication of JP2021504421A5 publication Critical patent/JP2021504421A5/ja
Application granted granted Critical
Publication of JP7327724B2 publication Critical patent/JP7327724B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020529538A 2017-11-30 2018-11-30 小麦過敏症を処置するためのhmoの混合物 Active JP7327724B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201700680 2017-11-30
DKPA201700680 2017-11-30
PCT/IB2018/059497 WO2019106618A1 (en) 2017-11-30 2018-11-30 Mixture of hmos for treating wheat sensitivity

Publications (3)

Publication Number Publication Date
JP2021504421A JP2021504421A (ja) 2021-02-15
JP2021504421A5 true JP2021504421A5 (https=) 2022-01-06
JP7327724B2 JP7327724B2 (ja) 2023-08-16

Family

ID=66664807

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020529538A Active JP7327724B2 (ja) 2017-11-30 2018-11-30 小麦過敏症を処置するためのhmoの混合物

Country Status (7)

Country Link
US (2) US11452736B2 (https=)
EP (1) EP3716984B1 (https=)
JP (1) JP7327724B2 (https=)
KR (2) KR20250058077A (https=)
CN (1) CN111698994A (https=)
ES (1) ES2987964T3 (https=)
WO (1) WO2019106618A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3782480A4 (en) 2018-03-29 2022-01-12 Morinaga Milk Industry Co., Ltd. NUTRITIONAL COMPOSITION, FOOD/DRINK COMPOSITION USING A NUTRITIONAL COMPOSITION AND MODIFIED MILK POWDER USING A NUTRITIONAL COMPOSITION
CN113194960A (zh) * 2018-12-19 2021-07-30 格礼卡姆股份公司 用于治疗使用低fodmap饮食的人的组合物和方法
KR20220017988A (ko) * 2019-06-05 2022-02-14 글리콤 에이/에스 비-셀리악 밀 및/또는 글루텐 민감성을 앓고 있는 환자에서 증상 치료에 사용하기 위한 모유 올리고사카라이드
JP2022132724A (ja) * 2021-03-01 2022-09-13 国立研究開発法人農業・食品産業技術総合研究機構 免疫グロブリンa分泌促進剤
WO2022218960A1 (en) * 2021-04-13 2022-10-20 Frieslandcampina Nederland B.V. Nutritional composition for stimulationg bifidobacteria

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
WO2007101862A1 (en) 2006-03-09 2007-09-13 Centre National De La Recherche Scientifique (Cnrs) Method of producing sialylated oligosaccharides
EP2405524B1 (en) 2009-03-05 2015-10-07 Nissan Motor Co., Ltd. Bipolar secondary cell and method for producing the same
CN102459294A (zh) 2009-04-07 2012-05-16 格礼卡姆股份公司 2’-o-岩藻糖基乳糖的合成
ES2651067T3 (es) * 2009-07-06 2018-01-24 Children's Hospital Medical Center Inhibición de la inflamación con oligosacáridos de la leche
EP3241836B1 (en) 2010-02-19 2024-10-30 Glycom A/S Polymorph of a tetrasaccharide containing nacetyl-lactosamine
WO2011100979A1 (en) 2010-02-19 2011-08-25 Glycom A/S Production of 6'-o-sialyllactose and intermediates
AU2011278236A1 (en) 2010-07-16 2013-02-07 Glycom A/S Derivatization of oligosaccharides
MY191538A (en) * 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
CA2822219C (en) * 2010-12-31 2020-12-29 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
US20120171166A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
US20140187474A1 (en) * 2011-02-16 2014-07-03 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic use of mucin glycans
WO2012113404A1 (en) 2011-02-21 2012-08-30 Glycom A/S Novel glycosyl phosphites
CN103443113A (zh) 2011-03-18 2013-12-11 格力康公司 新型含岩藻糖的糖类衍生物的合成
WO2012155916A1 (en) 2011-05-13 2012-11-22 Glycom A/S Manufacture of lacto-n-tetraose
CN103562401A (zh) 2011-05-13 2014-02-05 格力康公司 产生人乳寡糖(hmo)或其前体的方法
CN103562214B9 (zh) 2011-05-13 2016-12-14 格力康公司 人乳寡糖(hmo)或其前体的多样化
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
EP2760875A4 (en) 2011-09-30 2015-08-26 Glycom As SYNTHESIS OF HMO NUCLEAR STRUCTURES
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
WO2013139344A1 (en) 2012-03-20 2013-09-26 Glycom A/S Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof
CA2893217C (en) * 2012-12-18 2017-11-28 Abbott Laboratories Human milk oligosaccharides to ameliorate symptoms of stress
EP2935300B1 (en) * 2012-12-18 2025-01-22 Glycom A/S Novel polymorphs of lnnt
US20160120915A1 (en) * 2013-06-10 2016-05-05 New York University Methods for manipulating immune responses by altering microbiota
AU2014350419B2 (en) * 2013-11-15 2019-10-24 Société des Produits Nestlé S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by C-section
ES2870425T3 (es) * 2014-10-29 2021-10-27 Biogaia Ab Uso de L. reuteri para la prevención o el tratamiento de la disbiosis de microbiota en la vida temprana
EP3212197A4 (en) * 2014-10-29 2018-07-11 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
EP3229812A4 (en) 2014-12-08 2018-10-03 Glycom A/S Synthetic composition for treating metabolic disorders
US20170000830A1 (en) * 2015-07-01 2017-01-05 Rakesh Saini Compositions for Relieving the Symptoms of Gluten Sensitivity and Methods of Use Thereof
ES2886951T3 (es) 2015-09-14 2021-12-21 Glycom As Composición para su uso en la modulación de la microbiota
DK3452050T3 (da) 2016-05-05 2023-02-20 Glycom As Composition comprising hmos for the treatment of noninfectious diarrhoea
JP2020513014A (ja) * 2017-04-07 2020-04-30 チルドレンズ ホスピタル メディカル センター 2’−フコシルラクトース化合物による炎症性腸疾患の治療
US11602545B2 (en) * 2017-12-05 2023-03-14 Glycom A/S Human milk oligosaccharides for treating migraine
WO2019123316A1 (en) 2017-12-22 2019-06-27 Glycom A/S Composition comprising hmos for preventing or reducing nociception

Similar Documents

Publication Publication Date Title
JP2021504421A5 (https=)
JP2021504420A5 (https=)
Appanna Dysbiosis, probiotics, and prebiotics: in diseases and health
JP2017533915A5 (https=)
JP2009535419A5 (https=)
RU2005121665A (ru) Пребиотические композиции
Ramos-Gallardo Chronic wounds in burn injury: a case report on importance of biofilms
TWI640313B (zh) 戈氏副擬桿菌用於抑制肥胖之用途
CN105030841A (zh) Akkermansia muciniphila BAA-835菌株的应用
JP2020178685A (ja) 腸管障害の予防、治療又は抑制用組成物
CN103976359B (zh) 食品营养强化组合物及其应用、保健食品及其制备方法
CN109419817B (zh) 戈氏副拟杆菌用于降低胰岛素抗性及提升葡萄糖耐受性的用途
Fatima et al. Nutritional supplements and their use in the treatment of malnutrition in developing countries
Green et al. Chemotherapy in the geriatric population.
CN105380031A (zh) 一种保健食品及其制备方法
Waitzberg Efficacy of Nutritional Support: Evidence-Based Nutrition
Hansen The clinical diagnosis of acute rhinosinusitis and its therapeutic consequences
Prousky The use of Niacinamide and Solanaceae (Nightshade) Elimination in the Treatment of Osteoarthritis.
CN110101757A (zh) 一种适用于痛风及高尿酸人群的营养组合物
RU2593584C1 (ru) Средство для восстановления кишечного микробиоценоза при дисбиозах
Wang 22 Human Clinical Trial for Nutraceuticals and Functional Foods
Gumble et al. Examination of ghrita on various types of chronic diseases in pediatrics
Gupta et al. Traditional beliefs and practices among graduate mothers regarding various paediatric ailments
CN106511447A (zh) 一种细胞障碍修复营养补充方法及其药物配方
Marques et al. Limited health literacy and its association with poor surgical outcomes under a colorectal enhanced recovery after surgery (ERAS) program